HKUMed reveals that Resmetirom, a drug for treating metabolic dysfunction-associated fatty liver disease (MAFLD), has th...The University of Hong Kong
Professor Irene Ng Oi-lin (left) remarks that their next step is to validate relevant biomarkers in larger patient cohor...The University of Hong Kong
Artificial intelligence learns to make sense of childhood cancer survivors’ health care needs...St. Jude Children's Research Hospital
Tumor cells in the treatment-sensitive group of patients specifically upregulated MHC-II (tumor-specific Major Histocomp...Science China Press
